搜索临床试验以:西妥昔单抗、卡培他滨
总计4844个结果
-
South Eastern European Research Oncology GroupRoche Pharma AG未知
-
Azienda USL 4 PratoUniversità degli Studi di Brescia终止
-
Peking University Cancer Hospital & InstitutePeking University People's Hospital; Peking Union Medical College Hospital招聘中
-
Jiangsu HengRui Medicine Co., Ltd.未知
-
University Health Network, TorontoNational Cancer Institute (NCI)完全的
-
Memorial Sloan Kettering Cancer CenterGlaxoSmithKline完全的
-
Dutch Colorectal Cancer GroupSanofi; Roche Pharma AG终止
-
Norwegian Breast Cancer Group完全的
-
Children's Oncology GroupNational Cancer Institute (NCI)主动,不招人EBV 相关的移植后淋巴增生性疾病 | 单形性移植后淋巴增生性疾病 | 多态性移植后淋巴增生性疾病 | 复发性单形性移植后淋巴增生性疾病 | 复发性多态性移植后淋巴增生性疾病 | 难治性单形性移植后淋巴增生性疾病 | 难治性多态性移植后淋巴增生性疾病美国
-
Cancer Research NetworkHoffmann-La Roche完全的
-
University of California, DavisNational Cancer Institute (NCI)完全的
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)终止
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)完全的
-
Indiana University School of MedicineAventis Pharmaceuticals完全的
-
Roswell Park Cancer Institute完全的
-
Fudan University暂停
-
Sun Yat-sen University招聘中